NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Neuronetics, Inc. STIM
10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$149.2M
▲ 99.2% vs FY2024
EPS · FY25
$-0.59
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-155.7%
Net margin · FY25
-26.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 149.2M
Revenue, FY2025 · full 10-year series below
Revenue
Net income
The company lost 26 cents on every revenue dollar this year.
Per share
USD -0.59
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-155.7%
Return on equity, FY2025
ROE
Operating margin-21.1%
Net margin-26.1%
Return on assets-27.6%
Each USD of equity lost 156 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+24.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+31.8%
+24.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2025
Change, 5 years+64.0%
Change, 10 years—
The share count grew 64% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 141.6M
total assets, end of FY2025
Total assetsUSD 141.6M
EquityUSD 22.4M
CashUSD 28.1M
Gross debtUSD 65.8M
Net debtUSD 37.7M
Current ratio2.02×
Net debt stands at 168% of equity.
History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.59
−1.38
−1.05
−1.38
−1.22
−1.46
−1.58
−2.69
−86.34
−76.95
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
ROE %
−155.7
−141.2
−66.2
−52.3
−56.4
−74.9
−48.9
·
·
·
Shares out B
0.07
0.06
0.03
0.03
0.03
0.02
0.02
0.02
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
38 of 38
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed